Klonopin is a narcotic drug

Law on the traffic in narcotics (Narcotics Act - BtMG)
Annex III (to Section 1 Paragraph 1)
Marketable and prescription narcotics

 Column 1contains the International Nonproprietary Names (INN) of the World Health Organization. When designating a substance, the INN has priority over all other designations.Column 2contains other unprotected substance names (short names or common names). If there is no INN for a substance, the name in bold in this column can be used for its unique name. All other names not printed in bold are scientifically ambiguous. They are therefore to be used in conjunction with the designation in column 3.Column 3contains the chemical substance name according to the nomenclature of the International Union of Pure and Applied Chemistry (IUPAC). If no designation is given in column 1 or 2, that of column 3 is to be used. INNother unprotected or common nameschemical names (IUPAC)Alfentanil-N- {1- [2- (4-Ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl) ethyl] -4-methoxymethyl-4-piperidyl} - N -phenylpropanamideAllobarbital-5,5-diallyl barbituric acidAlprazolam-8-Chloro-1-methyl-6-phenyl-4H- [1,2,4] triazolo [4,3-a] [1,4] benzodiazepine
-
except in preparations that contain up to 1 mg alprazolam per divided form without another substance from Annexes I to III -
AmfepramonDiethyl propion2-diethylamino-1-phenylpropan-1-one
-
with the exception of preparations without delayed release of active substances, which without another substance from Annexes I to III up to 22 mg per divided form, and in preparations with delayed release of active substance, which without another substance from Annexes I to III up to 64 mg of amfepramone per divided form , calculated as base, contained -
Amfetamineamphetamine(RS) -1-phenylpropan-2-ylazaneAmobarbital-5-ethyl-5-isopentylbarbituric acidBarbital-5,5-diethylbarbituric acid
-
except in preparations that
a)
without another substance from appendices I to III up to 10 percent or
b)
without being used on or in the human or animal body, are used exclusively for diagnostic or analytical purposes and without any other substance from Annexes I to III contain no more than 25 g barbital, calculated as acid, per packaging unit -
Bromazepam-7-Bromo-5- (2-pyridyl) -1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations that contain up to 6 mg bromazepam per divided form without another substance from Annexes I to III -
Brotizolam-2-Bromo-4- (2-chlorophenyl) -9-methyl-6H-thieno [3,2-f] [1,2,4] triazolo [4,3-a] [1,4] diazepine
-
except in preparations which, without another substance from Annexes I to III, contain up to 0.02 per cent or, per divided form, up to 0.25 mg of brotizolam -
Buprenorphine-(5R, 6R, 7R, 14S) -17-Cyclopropyl-methyl-4,5-epoxy-7 - [(S) -2-hydroxy-3,3-dimethylbutan-2-yl] -6-methoxy-6, 14-ethanomorphinan-3-olCamazepam-(7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-enzodiazepin-3-yl) (dimethyl carbamate)-cannabis
(Marijuana, Plants and Plants
parts of the cannabis genus
belonging plants)-- only from a cultivation that is carried out for medical purposes under state control in accordance with Articles 23 and 28 paragraph 1 of the 1961 Single Convention on Narcotic Drugs, as well as in preparations that are approved as finished medicinal products -Cathine(+) - norpseudoephedrine (D-norpseudoephedrine)(1S, 2S) -2-amino-1-phenylpropan-1-ol
-
except in preparations which, without another substance from Annexes I to III, contain up to 5 percent as a solution, but not more than 1,600 mg per packaging unit or per divided form up to 40 mg cathine, calculated as base -
Chlordiazepoxide-7-chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide
-
except in preparations that contain up to 25 mg of chlordiazepoxide per divided form without another substance from Annexes I to III -
Clobazam-7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,5-benzodiazepine-2,4 (5H) -dione
-
except in preparations which, without another substance from Annexes I to III, contain up to 0.2 percent as a suspension, but not more than 300 mg per packaging unit, or up to 30 mg of clobazam per divided form -
Clonazepam-5- (2-chlorophenyl) -7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations which contain up to 0.25 per cent as a drop solution without another substance from Annexes I to III, but not more than 250 mg per packaging unit or per divided form up to 2 mg clonazepam -
Clorazepate-(RS) -7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylic acid
-
except in preparations which, without another substance from Annexes I to III, contain up to 50 mg per divided form, as dry substance only for parenteral use up to 100 mg, chlorazepate as dipotassium salt -
Clotiazepam-5- (2-Chlorophenyl) -7-ethyl-1-methyl-1,3-dihydro-2H-thieno [2,3-e] [1,4] diazepin-2-one
-
except in preparations that contain up to 20 mg clotiazepam per divided form without another substance from Annexes I to III -
Cloxazolam-10-Chloro-11b- (2-chlorophenyl) -2,3,7,11b-tetrahydro [1,3] oxazolo [3,2-d] [1,4] benzodiazepin-6 (5H) -one-Cocaine (benzoylecgonine methyl ester)Methyl [3ß- (benzoyloxy) tropane-2ß-carboxylate]-Codeine (3-methylmorphine)4,5α-epoxy-3-methoxy-17-methylmorphine-7-en-6α-ol
-
except in preparations which, without another substance from Annexes I to III, contain up to 2.5 per cent or, per divided form, up to 100 mg codeine, calculated as a base. For exempt preparations that are prescribed for people dependent on narcotics or alcohol, however, the provisions on prescribing and dispensing narcotics apply. -
Delorazepam-7-chloro-5- (2-chlorophenyl) -1,3-dihydro-2H-1,4-benzodiazepin-2-oneDexamfetamineDexamphetamine(S) -1-phenylpropan-2-ylazaneDexmethylphenidate-Methyl [(R, R) (phenyl) (2-piperidyl) acetate]-Diamorphine[(5R, 6S) -4,5-epoxy-17-methylmorphine-7-en-3,6-diyl] diacetate
-
only in preparations that are approved for substitution treatment -
Diazepam-7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations which, without another substance from Annexes I to III, contain up to 1 percent as syrup or drip solution, but not more than 250 mg per packaging unit, or up to 10 mg diazepam per divided form -
Dihydrocodeine-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol
-
except in preparations which, without another substance from Annexes I to III, contain up to 2.5 per cent or, per divided form, up to 100 mg of dihydrocodeine, calculated as a base. For exempt preparations that are prescribed for people dependent on narcotics or alcohol, however, the provisions on prescribing and dispensing narcotics apply. -
Dronabinol-(6aR, 10aR) -6,6,9-trimethyl-3-pentyl-6a, 7,8,10a-tetrahydro-6H-benzo [c] chromen-1-olEstazolam-8-chloro-6-phenyl-4H- [1,2,4] triazolo [4,3-a] benzodiazepine
-
except in preparations that contain up to 2 mg of estazolam per divided form without another substance from Annexes I to III -
Ethylloflazepat-Ethyl [7-chloro-5- (2-fluorophenyl) -2-oxo-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylate]Etizolam-4- (2-Chlorophenyl) -2-ethyl-9-methyl-6H-thieno [3,2-f] [1,2,4] triazolo [4,3-a] [1,4] diazepineEtorphine-(5R, 6R, 7R, 14R) -4,5-epoxy-7 - [(R) -2-hydroxypentan-2-yl] -6-methoxy-17-methyl-6,14-ethenomorphinan-3-olFenetylline-1,3-Dimethyl-7- [2- (1-phenylpropan-2-ylamino) ethyl] -3,7-dihydro-2H-purine-2,6 (1H) -dioneFenproporex-(RS) -3- (1-Phenylpropan-2-ylamino) propanenitrile
-
except in preparations which, without another substance from Annexes I to III, contain up to 11 mg Fenproporex, calculated as base, per divided form -
Fentanyl-N- (1-phenethyl-4-piperidyl) -N-phenylpropanamideFludiazepam-7-chloro-5- (2-fluorophenyl) -1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-oneFlunitrazepam-5- (2-fluorophenyl) -1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-oneFlurazepam-7-chloro-1- (2-diethylaminoethyl) -5- (2-fluorophenyl) -1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations that contain up to 30 mg of flurazepam per divided form without another substance from Annexes I to III -
Halazepam-7-chloro-5-phenyl-1- (2,2,2-trifluoroethyl) -1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations which, without another substance from Annexes I to III, contain up to 120 mg halazepam per divided form -
Haloxazolam-10-Bromo-11b- (2-fluorophenyl) -2,3,7,11b-tetrahydro [1,3] oxazolo [3,2-d] [1,4] benzodiazepin-6 (5H) -oneHydrocodoneDihydrocodeinone4,5α-epoxy-3-methoxy-17-methylmorphinan-6-oneHydromorphoneDihydromorphinone4,5α-epoxy-3-hydroxy-17-methylmorphinan-6-one-γ-hydroxybutyric acid (GHB)4-hydroxybutanoic acid
-
except in preparations for injection which, without another substance from Annexes I to III, contain up to 20 per cent and, per divided form, up to 2 g of gamma-hydroxybutyric acid, calculated as acid -
Ketazolam-11-chloro-2,8-dimethyl-12b-phenyl-8,12b-dihydro-4H- [1,3] oxazino [(3,2-d] [1,4] benzodiazepine-4,7 (6H) - dion
-
except in preparations that contain up to 45 mg of ketazolam per divided form without another substance from Annexes I to III -
LevacetylmethadolLevomethadyl Acetate (LAAM)[(3S, 6S) -6-dimethylamino-4,4-diphenylheptan-3-yl] acetateLevomethadone-(R) -6-Dimethylamino-4,4-diphenylheptan-3-oneLisdexamfetamine-(2S) -2,6-diamino- N - [(2S) -1-phenylpropan-2-yl] hexanamideLoprazolam-6- (2-Chlorophenyl) -2 - [(Z) -4-methylpiperazin-1-ylmethylene] -8-nitro-2,4-dihydro-1H-imidazo [1,2-a] [1,4] benzodiazepine -1-on
-
except in preparations which contain up to 2.5 mg loprazolam per divided form without another substance from Annexes I to III -
Lorazepam-(RS) -7-chloro-5- (2-chlorophenyl) -3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations which, without another substance from Annexes I to III, contain up to 2.5 mg lorazepam per divided form -
Lormetazepam-7-chloro-5- (2-chlorophenyl) -3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations that contain up to 2 mg lormetazepam per divided form without another substance from Annexes I to III -
Medazepam-7-chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine
-
except in preparations that contain up to 10 mg medazepam per divided form without another substance from Annexes I to III -
Methadone-(RS) -6-Dimethylamino-4,4-diphenylheptan-3-oneMethylphenidate-Methyl [(RS; RS) (phenyl) (2-piperidyl) acetate]MethylphenobarbitalMephobarbital(RS) -5-ethyl-1-methyl-5-phenylbarbituric acid
-
except in preparations which, without another substance from Annexes I to III, contain up to 200 mg methylphenobarbital, calculated as acid, per divided form -
Midazolam-8-chloro-6- (2-fluorophenyl) -1-methyl-4H-imidazo [1,5-a] [1,4] benzodiazepine
-
except in preparations which, without another substance from Annexes I to III, contain up to 0.2 per cent or up to 15 mg of midazolam per divided form -
-Morphine(5R, 6S) -4,5-epoxy-17-methyl-morphine-7-en-3,6-diolNabilone-(6aRS, 10aRS) -1-Hydroxy-6,6-dimethyl-3- (2-methyloctan-2-yl) -6,6a, 7,8,10,10a-hexahydro-9H-benzo [c] chromene- 9-onNimetazepam-1-methyl-7-nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-oneNitrazepam-7-nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations which, without another substance from Annexes I to III, contain up to 0.5 per cent as a drip solution per divided form, but not more than 250 mg per packaging unit, or up to 10 mg nitrazepam per divided form -
North Azepam-7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations which, without another substance from Annexes I to III, contain up to 0.5 per cent as a drip solution per divided form, but not more than 150 mg per packaging unit, or up to 15 mg of nordazepam per divided form -
Normethadone-6-dimethylamino-4,4-diphenyl-hexan-3-one-opium
(the coagulated sap of the plants belonging to the species Papaver somniferum)-
-
except in preparations that are manufactured according to a process technology described in the homeopathic part of the pharmacopoeia, if the final concentration does not exceed the sixth decimal power -
Oxazepam-7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzo-diazepin-2-one
-
except in preparations that contain up to 50 mg oxazepam per divided form without another substance from Annexes I to III -
Oxazolam-(2RS, 11bSR) -10-Chloro-2-methyl-11b-phenyl-2,3,7,11b-tetrahydro [1,3] oxazolo [3,2-d] [1,4] benzodiazepine-6 ​​(5H ) -on
-
except in preparations which contain up to 20 mg oxazolam per divided form without another substance from Annexes I to III -
Oxycodone14-hydroxydihydrocodeinone4,5α-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one-Papaver somniferum
(Plants and parts of plants, excluding the seeds, of plants belonging to the species Papaver somniferum (including the subspecies setigerum))-
-
except if they are used for ornamental purposes (with the exception of cultivation) and if their morphine content does not exceed 0.02 per cent when dry; In this case, the narcotics regulations apply to import, export and transit -
-
except in preparations that are manufactured according to a process technology described in the homeopathic part of the pharmacopoeia, if the final concentration does not exceed the fourth decimal power -
-
except in preparations which contain up to 0.015 per cent of morphine, calculated as a base, without another substance from Annexes I to III and which are composed of one or more other components in such a way that the narcotic cannot be easily applied or in can be recovered to an extent that is dangerous to public health -
Pemoline-2-imino-5-phenyl-1,3-oxazolidin-4-one
-
except in preparations which, without another substance from Annexes I to III, contain up to 20 mg pemoline, calculated as base, per divided form -
Pentazocine-(2R, 6R, 11R) -6,11-dimethyl-3- (3-methylbut-2-en-1-yl) -1,2,3,4,5,6-hexahydro-2,6-methano- 3-benzazocin-8-olPentobarbital-(RS) -5-ethyl-5- (pentan-2-yl) barbituric acidPethidine-Ethyl (1-methyl-4-phenyl-piperidine-4-carboxylate)-Phenazepam7-Bromo-5- (2-chlorophenyl) -1,3-dihydro-2H-1,4-benzodiazepin-2-onephenobarbital-5-ethyl-5-phenylbarbituric acid
-
except in preparations which, without another substance from Annexes I to III, contain up to 10 per cent or, per divided form, up to 300 mg phenobarbital, calculated as acid -
Phentermine-2-benzylpropan-2-ylazane
-
except in preparations which, without another substance from Annexes I to III, contain up to 15 mg phentermine, calculated as a base, per divided form -
Pinazepam-7-chloro-5-phenyl-1- (prop-2-yn1-yl) -1,3-dihydro-2H-1,4-benzodiazepin-2-onePipradrol-Diphenyl (2-piperidyl) methanolPiritramide-1 '- (3-cyano-3,3-diphenylpropyl) [1,4'-bipiperidine] -4'-carboxamidePrazepam-7-chloro-1-cyclopropylmethyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations that contain up to 20 mg of prazepam per divided form without another substance from Annexes I to III -
Remifentanil-Methyl {3- [4-methoxycarbonyl-4- (N-phenylpropanamido) piperidino] propanoate}Secobarbital-5-allyl-5- (pentan-2-yl) barbituric acidSufentanil-N- {4-methoxymethyl-1- [2- (2-thienyl) ethyl] -4-piperidyl} -N-phenylpropanamideTapentadol-3 - [(2R, 3R) -1-dimethylamino-2-methylpentan-3-yl] phenolTemazepam-(RS) -7-Chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations which, without another substance from Annexes I to III, contain up to 20 mg temazepam per divided form -
Tetrazepam-7-chloro-5- (cyclohex-1-enyl) -1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
-
except in preparations which contain up to 100 mg tetrazepam per divided form without another substance from Annexes I to III -
Tilidinetrans-tilidineEthyl [(1RS, 2SR) -2-dimethyl-amino-1-phenylcyclohex-3-enecarboxylate]
-
except in solid preparations with delayed release of active ingredients which, without another substance from Annexes I to III, contain up to 300 mg of tilidine per divided form, calculated as a base, and, based on this amount, at least 7.5 per cent of naloxone hydrochloride -
Triazolam-8-Chloro-6- (2-chlorophenyl) -1-methyl-4H- [1,2,4] triazolo [4,3-a] [1,4] benzodiazepine
-
except in preparations that contain up to 025 mg of triazolam per divided form without another substance from Annexes I to III -
Zolpidem-N, N-Dimethyl-2- [6-methyl-2- (p-toly) imidazo [1,2-a] pyridin-3-yl] acetamide
-
except in preparations for oral use which, without another substance from Annexes I to III, contain up to 8.5 mg zolpidem per divided form, calculated as a base -
-
the salts and molecular compounds of the substances listed in this annex, if they are used by a doctor, dentist or veterinarian according to the knowledge of medical science;
-
the preparations of the substances listed in this annex, if they are not
a)
without being used on or in the human or animal body, serve exclusively diagnostic or analytical purposes and their content of one or more narcotics, lyophilisates and corresponding mixtures of substances in the ready-to-use solution does not exceed 0.01 percent in each case or the substances isotope-modified in the preparations or
b)
are particularly excluded. For exempt preparations - except for those with codeine or dihydrocodeine - the narcotics regulations on import, export and transit apply. Preparations exempted under letter b of the Barbital item can, however, be imported, exported or carried out without authorization in accordance with Section 11 of the Narcotics Act, if improper use is not to be feared under the circumstances.